1,081
edits
Changes
no edit summary
<p class="orangeHeader"><a href="http://www.ontariogenomics.ca">http://www.ontariogenomics.ca</a></p>
<strong>The Ontario Genomics Institute</strong> (OGI) was established in 2000 as a non-profit corporation with a mission to provide leadership for Ontario in helping build a globally-competitive life sciences sector by creating leverageable genomics resources with top-notch research.
<p>OGI, one of six genome centres across Canada, is part of the new MaRS Discovery District, serving the innovation pipeline in Ontario. Working with Genome Canada, Ontario’s Ministry of Research and Innovation (MRI), and other private and public sector partners, OGI currently oversees a $500 million portfolio of 33 leading-edge genomics and proteomics research projects as well as a world-class technology platform at The Centre for Applied Genomics (TCAG) based in Toronto.</p>
<p>Ontario-led international projects, an important part of OGI’s portfolio, are underway through: the Structural Genomics Consortium (SGC), a shared research initiative at the Universities of Oxford, Toronto and the Karolinska Institute in Stockholm, Sweden; and the International Regulome Consortium (IRC), which includes scientists from Australia, Britain, Canada, France, the Netherlands, Singapore, and the U.S.; and a Genome Canada-Genoma España initiative.</p>
<p>OGI's three major roles are: </p>
<ul>
<li>Attracting investment for internationally recognized genomics-based or genomics-derived research that is of strategic importance to Ontario and all of the world, </li>
<li>Accelerating the impact of genomics resources created through research to increase business development in Ontario, in Canada, and internationally, </li>
<li>Increasing public awareness of genomics and its impact on society through education, dialogue on social and ethical issues, and public outreach programs. </li>
</ul>
<strong>The Ontario Genomics Institute</strong> (OGI) was established in 2000 as a non-profit corporation with a mission to provide leadership for Ontario in helping build a globally-competitive life sciences sector by creating leverageable genomics resources with top-notch research.
<p>OGI, one of six genome centres across Canada, is part of the new MaRS Discovery District, serving the innovation pipeline in Ontario. Working with Genome Canada, Ontario’s Ministry of Research and Innovation (MRI), and other private and public sector partners, OGI currently oversees a $500 million portfolio of 33 leading-edge genomics and proteomics research projects as well as a world-class technology platform at The Centre for Applied Genomics (TCAG) based in Toronto.</p>
<p>Ontario-led international projects, an important part of OGI’s portfolio, are underway through: the Structural Genomics Consortium (SGC), a shared research initiative at the Universities of Oxford, Toronto and the Karolinska Institute in Stockholm, Sweden; and the International Regulome Consortium (IRC), which includes scientists from Australia, Britain, Canada, France, the Netherlands, Singapore, and the U.S.; and a Genome Canada-Genoma España initiative.</p>
<p>OGI's three major roles are: </p>
<ul>
<li>Attracting investment for internationally recognized genomics-based or genomics-derived research that is of strategic importance to Ontario and all of the world, </li>
<li>Accelerating the impact of genomics resources created through research to increase business development in Ontario, in Canada, and internationally, </li>
<li>Increasing public awareness of genomics and its impact on society through education, dialogue on social and ethical issues, and public outreach programs. </li>
</ul>